IP / Patents
SMS sought to develop and protect significant intellectual property mainly patents with respect to manufacturing processes and products. The following table shows the patents for which we have obtained registrations under Patent Co-operation Treaty (PCT) :
 
Sl. Title Number Publication No. & Date
1 A Novel Process For The Preparation Of Indole Derivatives (Sumatriptan) PCT/IN03/00183 WO 2004/099141 A1 18.11.2004
2 One-Pot Preparation Of S-(Guinidino-4-Yl-Methyl)-Isothiourea Dihydrochloride (Famotidine) PCT/IN 03/00252 WO2005/009986 A1 03.02.2005
3 A Process For The Preparation Of Debitterised And Defatted Trigonella Foenum Graecum Containing 4-Hydroxy Isoleucine. PCT/IN 03/00253 WO 2005/009453 A1 03.02.2005
4 A Novel Synthesis Of 2-Azabicyclic-3-Carboxylic Acids, Useful As Important Drug Intermediates.(Ramipril) PCT/IN 03/00367 PUBLISHED ON 02.06.2005 WO2005/049567 A1
5 A Process For Industrially Viable Preparation Of (S,S,S) Phenylmethyl-2-Azabicyclo-(3,3,0)-Octane-3-Carboxylate Tosylate. (Ramipril - Intermediate) PCT/IN 03/00369 PUBLISHED ON 02.06.2005 WO2005/049568 A1
6 An Improved Process For The Manufacture Of High Pure Gemcitabine Hydrochloride (Gemcitabine - Purification) PCT/IN 04/00084 PUBLISHED ON 13.10.2005 WO 2005/095430 A1
7 An Improved Process For The Manufacture Of High Pure Gemcitabine Hydrochloride (Gemcitabine - Purification) PCT/IN 04/00084 PUBLISHED ON 13.10.2005 WO 2005/095430 A1
We have also made applications to Indian patents office as follows :
Sl. Title Number Publication No. & Date
8 A Process For The Preparation Of Quinapril Hydrochloride Of High Purity And Stability. 917/CHE/2004 13.09.2004
9 A Low Sodium Dietetic Mineral Salt (Fenudiet) 1430/CHE/2004 24.12.2004
10 Synthesis for quinozolinones and its conversion to an anticancer product gefitinib, 4-(3-chloro-4-flourophenylamino)-7-methoxy-6-[3-(4-orpholinyl)propoxy] (gefitinib) 219/CHE/2005 07.03.2005 Complete Spec
11 Synthesis Of 6-Hydroxy-7-Methoxy Quinazoline-4-(3h)-One Or Quinozolinone (Gefitinib-Int.) 218/CHE/2005 07.03.2005 Complete Spec
12 Synthesis of 2-deoxy –2,2-di fluoro-d-ribo furanose-3, 5-di(4-methyl/4-nitro-chloro) benzoate and its conversion to gemcitabine hydrochloride. (gemcitabine-intermediate) 240/CHE/2005 10.03.2005 Complete Spec
13 Process for industrially viable preparation of perindopril erbumine. (perindopril) 783/CHE/2005 23.06.2005 Complete Spec
14 Process for industrially viable preparation of esters of (s,s,s) octahydroindole-2-carboxylic acid (perindopril-intermediate) 784/CHE/2005 23.06.2005 Complete Spec
15 Process for industrially viable preparation of imidapril hydrochloride (imidapril) 1247/CHE/2005 06.09.2005 Complete Spec
16 Synthesis of 2-arylthio-2-methylamino-1-nitroethene – a useful intermediate for the manufacture of anti-ulcerative (ranitidine new intermediate) 1756/CHE/2005 01-12-05 Complete Spec
17 A novel process for the manufacture of pharmaceutical grade anti-ulceratives like ranitidine and nizatidine, by using a new intermediate and generating by-product 1755/CHE/2005 01-12-05 Complete Spec
 
We have entered into an agreement to supply Sumatriptan Succinate to Ranbaxy Laboratories Limited under Para IV which has filed Abbreviated New Drug Application (ANDA) with the US FDA using reference to our DMF.